Clinical trial
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
NCT00227695 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00227695 |
|---|---|
| Title | Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma |
| Official title | Comparing Two Schedules of Rituximab Maintenance in Rituximab-Responding Patients With Untreated, Chemotherapy Resistant or Relapsed Follicular Lymphoma: A Randomized Phase III Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | rituximab |
| Enrollment | 270 |
| Start date | Jun 8, 2004 |
| Primary completion | May 3, 2013 |
| Completion | Dec 19, 2017 |
| First posted | Sep 28, 2005 |
| Last update posted | May 15, 2019 |
| Countries | Brazil, Italy, North Macedonia, Serbia, Slovakia, South Africa, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: